RxDoctor Payments Data

Krishi Peddada, MD

Ophthalmology · Simpsonville, SCNPI 1588014393

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Genentech USA, Inc. at 38.4% of the total. 2025 is the largest year on record at $4,743, 8.4 times the $565 reported in 2019.

$8,762in general payments, 2019–2025

Across 114 payments — averaging $76.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$3K
  • Carl Zeiss Meditec USA, Inc.$1K
  • Apellis Pharmaceuticals, Inc.$633
  • Bausch & Lomb Americas Inc.$589
  • AbbVie$448
  • Genentech, Inc.$399
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$3,16036%
  • Travel & lodging$1,19814%
  • Food & beverage$4,40350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,762 in reported general payments places this provider in the 85th percentile of 293 ophthalmology providers in South Carolina.

See all ophthalmology providers in South Carolina

Medicare billing

Part B allowed, 2024
$5,298,487
Medicare patients
767
Services billed
72,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate80$3,482
Brimonidine Tartrate26$2,898
Difluprednate15$2,001
Ketorolac Tromethamine33$2,000
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$1,159
Latanoprost59$594
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat34$474
Ofloxacin39$456
Atropine Sulfate11$346
Timolol Maleate16$123
Dorzolamide Hcl13$97

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Simpsonville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →